How much does ldelalisib cost?

Idelalisib (Idelalisib) is a targeted therapy drug mainly used to treat adult patients with chronic lymphocytic leukemia (CLL) and anaplastic lymphoma (FL) and other B cell lymphomas. The uniqueness of this drug is that it targets the abnormal proliferation of white blood cells (lymphocytes) by inhibiting signaling pathways, thereby reducing the growth and spread of tumor cells and improving the patient's quality of life.

Idelalisi is not currently on the market in China, so it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channels. There are only original drugs of iderallis available abroad, mainly from the United States, and the price is as high as about 38,000 yuan.

Idelalisi is aPI3Kinhibitor that specifically inhibits the delta in the PI3kinase signaling pathway. span>subtype (δ-PI3K), this subtype plays a key role in the pathogenesis of B cell leukemia and lymphoma. PI3KThe PI3K signaling pathway plays an important role in cell growth, differentiation and survival. Therefore, by inhibiting this signaling pathway, idelaliside can reduce the growth and spread of leukemia and lymphoma cells.

Overall, idelalisib is a new treatment that shows promise in helping patients with chronic lymphocytic leukemia and anaplastic lymphoma. However, patients should use it under a doctor's supervision and pay close attention to any possible side effects. The treatment plan should be individually adjusted according to the patient's specific situation to ensure the best therapeutic effect. If you or someone you know needs to use idelalix, it is recommended to consult a medical professional for more detailed information and guidance.

xa0